Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate plus esketamine vs dexmedetomidine plus esketamine for bronchoscopy sedation
ChiCTR2200063338Phase 4Not yet recruiting
- Sponsor
- Ordos Central Hospital
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in None (2 arms), sponsored by Ordos Central Hospital. Primary endpoint: Operation completion success rate. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2200063338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063338.